Showing results (2011-2020 of 2,304) with videos related to
Sort By:
Pageof 231
Structure (London, England : 1993)|January 16, 2025
Structure of E6AP in complex with HPV16-E6 and p53 reveals a novel ordered domain important for E3 ligase activationSebastian Kenny, Shalini Iyer, Clinton A Gabel, et al.Cancer Immunology, Immunotherapy : CII|June 13, 2001
Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo systemC Renner, I Stehle, F T Lee, et al.Basic Research in Cardiology|August 30, 2002
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardiumChristopher S R Baker, David P Dutka, Domenico Pagano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitorXianhua Cao, Mark Bloomston, Tao Zhang, et al.Molecular and Cellular Biology|August 1, 1993
Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testesC Hall, W C Sin, M Teo, et al.International Journal of Radiation Biology|May 1, 1992
Direct comparison between protons and alpha-particles of the same LET: I. Irradiation methods and inactivation of asynchronous V79, HeLa and C3H 10T1/2 cellsD T Goodhead, M Belli, A J Mill, et al.The Journal of Physical Chemistry. A|July 13, 2006
Structure-optical property relationships in organometallic sydnonesThomas M Cooper, Benjamin C Hall, Daniel G McLean, et al.Nucleic Acid Therapeutics|May 30, 2019
Formulation of Biocompatible Targeted ECO/siRNA Nanoparticles with Long-Term Stability for Clinical Translation of RNAiNadia R Ayat, Zhanhu Sun, Da Sun, et al.Infection Control and Hospital Epidemiology|January 11, 2021
Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for <i>Escherichia coli</i> and <i>Klebsiella</i> bacteremiaYorgo Zahlanie, Brenton C Hall, Wenjing Wei, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workersM P Webber, W Moir, R Zeig-Owens, et al.Pageof 231